238 related articles for article (PubMed ID: 11884652)
1. Effects of depression and Parkinson's disease on cognitive functioning.
Norman S; Tröster AI; Fields JA; Brooks R
J Neuropsychiatry Clin Neurosci; 2002; 14(1):31-6. PubMed ID: 11884652
[TBL] [Abstract][Full Text] [Related]
2. Depression and dementia in Parkinson's disease. Catecholamine changes in the locus ceruleus, a basis for therapy.
Chan-Palay V
Adv Neurol; 1993; 60():438-46. PubMed ID: 8093581
[No Abstract] [Full Text] [Related]
3. [Role of demotivation and affective disorders in apathy in patients with Parkinson's disease without dementia and depression].
Delgadillo-Iniguez D; Derouesné C; Lacomblez L; Gély-Nargeot MC
Geriatr Psychol Neuropsychiatr Vieil; 2013 Jun; 11(2):197-207. PubMed ID: 23803637
[TBL] [Abstract][Full Text] [Related]
4. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
Meco G; Bernardi S
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
[TBL] [Abstract][Full Text] [Related]
6. Visual dysfunction in Parkinson disease without dementia.
Uc EY; Rizzo M; Anderson SW; Qian S; Rodnitzky RL; Dawson JD
Neurology; 2005 Dec; 65(12):1907-13. PubMed ID: 16282276
[TBL] [Abstract][Full Text] [Related]
7. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D
Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823
[TBL] [Abstract][Full Text] [Related]
8. Everyday cognitive failures and memory problems in Parkinson's patients without dementia.
Poliakoff E; Smith-Spark JH
Brain Cogn; 2008 Aug; 67(3):340-50. PubMed ID: 18358582
[TBL] [Abstract][Full Text] [Related]
9. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
Pålhagen SE; Carlsson M; Curman E; Wålinder J; Granérus AK
Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
[TBL] [Abstract][Full Text] [Related]
10. Depression in patients with Parkinson's disease: identification and treatment.
Jamieson DR; Jamieson AE
Br J Hosp Med (Lond); 2007 Sep; 68(9):485-8. PubMed ID: 17953306
[TBL] [Abstract][Full Text] [Related]
11. Impaired reproduction of second but not millisecond time intervals in Parkinson's disease.
Koch G; Costa A; Brusa L; Peppe A; Gatto I; Torriero S; Gerfo EL; Salerno S; Oliveri M; Carlesimo GA; Caltagirone C
Neuropsychologia; 2008 Apr; 46(5):1305-13. PubMed ID: 18215403
[TBL] [Abstract][Full Text] [Related]
12. Mood disturbances and cognitive functioning in Parkinson's disease: the effects of disease duration and side of onset of motor symptoms.
Foster PS; Drago V; Mendez K; Witt JC; Crucian GP; Heilman KM
J Clin Exp Neuropsychol; 2013; 35(1):71-82. PubMed ID: 23320400
[TBL] [Abstract][Full Text] [Related]
13. Effects of levodopa on cognitive functioning in moderate-to-severe Parkinson's disease (MSPD).
Morrison CE; Borod JC; Brin MF; Hälbig TD; Olanow CW
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1333-41. PubMed ID: 15480842
[TBL] [Abstract][Full Text] [Related]
14. Depressive symptom profile in Parkinson's disease: a comparison with depression in elderly patients without Parkinson's disease.
Ehrt U; Brønnick K; Leentjens AF; Larsen JP; Aarsland D
Int J Geriatr Psychiatry; 2006 Mar; 21(3):252-8. PubMed ID: 16477585
[TBL] [Abstract][Full Text] [Related]
15. Changes in cognitive functioning following treatment of late-life depression.
Butters MA; Becker JT; Nebes RD; Zmuda MD; Mulsant BH; Pollock BG; Reynolds CF
Am J Psychiatry; 2000 Dec; 157(12):1949-54. PubMed ID: 11097959
[TBL] [Abstract][Full Text] [Related]
16. The influence of depression on cognition in Parkinson's disease: a pattern of impairment distinguishable from Alzheimer's disease.
Tröster AI; Paolo AM; Lyons KE; Glatt SL; Hubble JP; Koller WC
Neurology; 1995 Apr; 45(4):672-6. PubMed ID: 7723954
[TBL] [Abstract][Full Text] [Related]
17. Application of depression rating scales in patients with Parkinson's disease with and without co-Occurring anxiety.
Calleo J; Williams JR; Amspoker AB; Swearingen L; Hirsch ES; Anderson K; Goldstein SR; Grill S; Lehmann S; Little JT; Margolis RL; Palanci J; Pontone GM; Weiss H; Rabins P; Marsh L
J Parkinsons Dis; 2013; 3(4):603-8. PubMed ID: 24275604
[TBL] [Abstract][Full Text] [Related]
18. Validity of the Dementia Rating Scale in assessing cognitive function in Parkinson's disease.
Brown GG; Rahill AA; Gorell JM; McDonald C; Brown SJ; Sillanpaa M; Shults C
J Geriatr Psychiatry Neurol; 1999; 12(4):180-8. PubMed ID: 10616865
[TBL] [Abstract][Full Text] [Related]
19. Screening for anxiety symptoms in Parkinson disease: a cross-sectional study.
Stefanova E; Ziropadja L; Petrović M; Stojković T; Kostić V
J Geriatr Psychiatry Neurol; 2013 Mar; 26(1):34-40. PubMed ID: 23407399
[TBL] [Abstract][Full Text] [Related]
20. Cognitive impairments in different stages of Parkinson's disease.
Starkstein SE; Bolduc PL; Preziosi TJ; Robinson RG
J Neuropsychiatry Clin Neurosci; 1989; 1(3):243-8. PubMed ID: 2521068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
